270 related articles for article (PubMed ID: 11821246)
1. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.
Ness RB; Cramer DW; Goodman MT; Kjaer SK; Mallin K; Mosgaard BJ; Purdie DM; Risch HA; Vergona R; Wu AH
Am J Epidemiol; 2002 Feb; 155(3):217-24. PubMed ID: 11821246
[TBL] [Abstract][Full Text] [Related]
2. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study.
Mosgaard BJ; Lidegaard O; Kjaer SK; Schou G; Andersen AN
Fertil Steril; 1997 Jun; 67(6):1005-12. PubMed ID: 9176436
[TBL] [Abstract][Full Text] [Related]
3. Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.
Asante A; Leonard PH; Weaver AL; Goode EL; Jensen JR; Stewart EA; Coddington CC
Fertil Steril; 2013 Jun; 99(7):2031-6. PubMed ID: 23552324
[TBL] [Abstract][Full Text] [Related]
4. Ovarian stimulation and borderline ovarian tumors: a case-control study.
Mosgaard BJ; Lidegaard O; Kjaer SK; Schou G; Andersen AN
Fertil Steril; 1998 Dec; 70(6):1049-55. PubMed ID: 9848294
[TBL] [Abstract][Full Text] [Related]
5. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.
Kurta ML; Moysich KB; Weissfeld JL; Youk AO; Bunker CH; Edwards RP; Modugno F; Ness RB; Diergaarde B
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1282-92. PubMed ID: 22707710
[TBL] [Abstract][Full Text] [Related]
6. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
7. Fertility drugs and risk of epithelial ovarian cancer in Italy.
Franceschi S; La Vecchia C; Negri E; Guarneri S; Montella M; Conti E; Parazzini F
Hum Reprod; 1994 Sep; 9(9):1673-5. PubMed ID: 7836516
[TBL] [Abstract][Full Text] [Related]
8. Treatment for infertility and risk of invasive epithelial ovarian cancer.
Parazzini F; Negri E; La Vecchia C; Moroni S; Franceschi S; Crosignani PG
Hum Reprod; 1997 Oct; 12(10):2159-61. PubMed ID: 9402274
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
[TBL] [Abstract][Full Text] [Related]
10. The risk of ovarian cancer after treatment for infertility.
Bristow RE; Karlan BY
Curr Opin Obstet Gynecol; 1996 Feb; 8(1):32-7. PubMed ID: 8777256
[TBL] [Abstract][Full Text] [Related]
11. Use of fertility drugs and risk of ovarian cancer.
Diergaarde B; Kurta ML
Curr Opin Obstet Gynecol; 2014 Jun; 26(3):125-9. PubMed ID: 24752005
[TBL] [Abstract][Full Text] [Related]
12. Assisted reproductive technology and ovarian cancer.
Devesa M; Barri PN; Coroleu B
Minerva Endocrinol; 2010 Dec; 35(4):247-57. PubMed ID: 21178919
[TBL] [Abstract][Full Text] [Related]
13. Risk of borderline ovarian tumors after fertility treatment - Results from a Danish cohort of infertile women.
Kristensen AK; Frandsen CLB; Nøhr B; Viuff JH; Hargreave M; Frederiksen K; Kjær SK; Jensen A
Gynecol Oncol; 2024 Jun; 185():108-115. PubMed ID: 38382167
[TBL] [Abstract][Full Text] [Related]
14. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
15. Infertility and risk of fatal ovarian cancer in a prospective cohort of US women.
Rodriguez C; Tatham LM; Calle EE; Thun MJ; Jacobs EJ; Heath CW
Cancer Causes Control; 1998 Dec; 9(6):645-51. PubMed ID: 10189051
[TBL] [Abstract][Full Text] [Related]
16. Treatment for fertility and risk of ovarian tumors of borderline malignancy.
Parazzini F; Negri E; La Vecchia C; Moroni S; Polatti A; Chiaffarino F; Surace M; Ricci E
Gynecol Oncol; 1998 Mar; 68(3):226-8. PubMed ID: 9570970
[TBL] [Abstract][Full Text] [Related]
17. Fertility drug use and risk of ovarian tumors: a debated clinical challenge.
Gadducci A; Guerrieri ME; Genazzani AR
Gynecol Endocrinol; 2013 Jan; 29(1):30-5. PubMed ID: 22946709
[TBL] [Abstract][Full Text] [Related]
18. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.
Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL
Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066
[TBL] [Abstract][Full Text] [Related]
19. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
